Cargando…
Management of Coronavirus 2019
Coronavirus 2019 (COVID-19) disease is the most recent global public health problem. It is caused by SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2), which is a RNA virus with a high mutation rate, belonging to the genus Coronavirus . The objective of this communication is to pr...
Autores principales: | Mehta, Chitra, Kataria, Sushila, Mehta, Yatin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416204/ http://dx.doi.org/10.1055/s-0040-1710401 |
Ejemplares similares
-
Management of refractory hypoxemia
por: Mehta, Chitra, et al.
Publicado: (2016) -
Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series
por: Mehta, Yatin, et al.
Publicado: (2021) -
Percutaneous Tracheostomy
por: Mehta, Yatin, et al.
Publicado: (2017) -
Percutaneous Tracheostomy
por: Mehta, Chitra, et al.
Publicado: (2017) -
Noninvasive Respiratory Devices in COVID-19
por: Mehta, Chitra, et al.
Publicado: (2022)